Subclinical chikungunya virus infection during pregnancy: immune and clinical characterization in a prospective cohort
Introduction Mosquito-borne viral infections are a rising global public health challenge, particularly for pregnant women. Chikungunya virus (CHIKV) infection is expanding beyond endemic regions, but maternal–fetal immune responses and pregnancy outcomes remain poorly characterized, especially for asymptomatic cases. Methods We analyzed maternal blood samples collected longitudinally from early pregnancy, with paired placental and umbilical cord tissues, and cord blood obtained at delivery, in a prospective Singapore cohort. CHIKV infection was determined by reverse transcription polymerase chain reaction (RT-PCR) and serological screening. Maternal systemic immune responses were characterized by multiplex profiling of circulating immune mediators. Antibody levels and neutralizing responses were assessed in maternal and cord blood sera, alongside clinical data on pregnancy and infant outcomes. Results and discussion Among 176 participants, three (1.7%) had laboratory evidence of CHIKV infection during pregnancy and nine (5.1%) had evidence of prior infection. No vertical transmission was detected, with undetectable CHIKV RNA and neonatal IgM levels in cord blood. Maternal and cord sera exhibited CHIKV-neutralizing activity, and a positive correlation between maternal and cord IgG titers supported transplacental transfer of IgG. In the three cases of infection during pregnancy, cytokine profiling suggested an attenuation of Th1-associated mediators while preserving factors involved in fetoplacental development. These maternal CHIKV infection cases experienced uncomplicated pregnancies, and all exposed infants were born appropriate for gestational age and achieved expected developmental milestones up to 12 months. Conclusion: Subclinical maternal CHIKV infection during pregnancy may not be associated with vertical transmission or adverse early clinical outcomes, and immune profiling suggests a potentially calibrated maternal immune response.
Authors
- Stacey K.H. Tay (ORCID: https://orcid.org/0000-0002-3077-4184)
- Benedict Yan (ORCID: https://orcid.org/0000-0001-6530-5372)
- Shiao‐Yng Chan (ORCID: https://orcid.org/0000-0002-3530-3023)
- Lisa F. P. Ng (ORCID: https://orcid.org/0000-0003-4071-5222)
- Liang Hui Loo (ORCID: https://orcid.org/0000-0002-4477-2614)
- Hannah E. J. Yong (ORCID: https://orcid.org/0000-0002-8814-752X)
- Eu‐Leong Yong (ORCID: https://orcid.org/0000-0001-6511-770X)
- Jiun Lee (ORCID: https://orcid.org/0000-0002-5233-5190)
- Paul Anantharajah Tambyah (ORCID: https://orcid.org/0000-0003-0405-771X)
- Siew‐Wai Fong (ORCID: https://orcid.org/0000-0002-5326-489X)
- Sarah Tan
- Nicholas Kim‐Wah Yeo (ORCID: https://orcid.org/0000-0002-8294-1474)
- Evelyn Chung Ning Law (ORCID: https://orcid.org/0000-0003-4683-7220)
- Anna X. Y. Loo
- Ka Lip Chew
Institutions
- Agency for Science, Technology and Research (SG)
- National University of Singapore (SG)
- National University Hospital (SG)
- National University Health System (SG)
- Infectious Diseases Labs (SG)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fimmu.2026.1993288
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00